About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Language Treatment for Progressive Aphasia | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT00957710

Language Treatment for Progressive Aphasia

Progressive aphasia is characterized by a steady and progressive loss of language skills in the presence of relatively preserved memory, attention, and thinking. The aim of this study is to slow the p...

Lead sponsor: Baycrest•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Baycrest

Collaborators

Canadian Institutes of Health Research (CIHR)

Age

40 - 80 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Diagnosis of progressive aphasia
•Native English speaker or fluent in English
•Adequate hearing and vision (not requiring more than +6 diopter correction)
•Willing and able to participate in each phase of the study (including two fMRI sessions)

Exclusion Criteria

•Contraindications to fMRI (e.g., claustrophobia, pacemaker, ferromagnetic implant)
•Current medical or psychiatric condition affecting cognition (other than progressive aphasia)

Related studies

Speech and Language Interventions for Italian People With PPA

NCT06739967 · Primary Progressive Aphasia(PPA)

UPenn Observational Research Repository on Neurodegenerative Disease

NCT04715399 · Frontotemporal Degeneration(FTD), Primary Progressive Aphasia(PPA), and more

Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia

NCT05741853 · Primary Progressive Aphasia, Dementia, and more

RECRUITINGPhase 1

Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology

NCT05184569 · Semantic Dementia

Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA

NCT03887481 · Logopenic Progressive Aphasia, Primary Progressive Aphasia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 27, 2015Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment7

Start dateAug 2009

Last updatedJan 27, 2015

Condition

Primary Progressive Aphasia Nonfluent Progressive Aphasia Semantic Dementia

Locations shown

Baycrest

Toronto, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 27, 2015Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions